Trial Profile
CRE8 in All Comers Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Acute coronary syndromes; Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 27 Jun 2016 Status changed from not yet recruiting to completed.
- 25 Sep 2012 New trial record